Edwards Receives FDA Approval For Expanded Indication Study Of SAPIEN 3 Valve
January 15, 2016 at 08:31 AM EST
Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical ...